{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T04:50:16Z","timestamp":1782190216992,"version":"3.54.5"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The bidirectional relationship between depression and type 2 diabetes (T2D) is well-established. Women are disproportionately affected by their co-occurrence, particularly during midlife, yet sex- and age-specific studies on phenotypic and mechanistic factors underlying risk for their co-occurrence are limited. The purpose of this study was to identify combined risk profiles (i.e., depression, T2D) in women during midlife and to determine if microRNAs (miRs) that are associated with high-risk profiles provide mechanistic insights into multimorbidity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>This study included baseline data from women during midlife (ages 40\u201364 years) who participated in the Diabetes Prevention Program (DPP) (n = 603). Unsupervised k-means clustering was used to identify multimorbid risk profiles. Clinical characteristics included for risk profiling included Beck Depression Inventory (BDI-I), age, BMI, waist circumference, triglycerides, high HDL, FBG, and HbA1c. Associations between risk profiles and individual miRs and principal components of co-expressed miRs were determined via logistic regression models adjusted for participant race and ethnicity. False discovery rate (q&amp;lt; 0.05) was used to control for multiple comparisons.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Two distinct profiles were identified, with the high-risk profile characterized by younger age yet higher adiposity, glycemic biomarkers, and depression symptom burden compared to the low-risk profile. MiR-320a and miR-320c were associated with increased odds of high-risk profile assignment, and a co-expression cluster enriched for miRs belonging to the miR-320 family (PC3) was significantly associated with increased odds of high-risk profile assignment. Across all models, Black race demonstrated at least threefold higher odds of high-risk profile assignment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>These findings highlight distinct multimorbid risk profiles in women during midlife, emphasizing the potential utility of integrated, multidimensional approaches for risk stratification. Findings also revealed mechanisms that may underly risk for co-occurrence of T2D and depression in women during midlife and potential therapeutic targets for prevention and treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1816057","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T04:32:56Z","timestamp":1782189176000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Co-expressed microRNAs associated with elevated psychometabolic risk phenotype in women during midlife"],"prefix":"10.3389","volume":"17","author":[{"given":"Kayla D.","family":"Longoria","sequence":"first","affiliation":[{"name":"Department of Physiological Nursing, University of California, San Francisco","place":["San Francisco, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin M.","family":"Stroebel","sequence":"additional","affiliation":[{"name":"Department of Physiological Nursing, University of California, San Francisco","place":["San Francisco, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghana","family":"Gadgil","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, San Francisco","place":["San Francisco, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Perez","sequence":"additional","affiliation":[{"name":"Rory Meyers College of Nursing, New York University","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly A.","family":"Lewis","sequence":"additional","affiliation":[{"name":"UCLA Health, University of California Los Angeles","place":["Los Angeles, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Weiss","sequence":"additional","affiliation":[{"name":"Department of Community Health Systems, University of California, San Francisco","place":["San Francisco, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Flowers","sequence":"additional","affiliation":[{"name":"Department of Physiological Nursing, University of California, San Francisco","place":["San Francisco, CA, United States"]},{"name":"Institute for Human Genetics, University of California, San Francisco","place":["San Francisco, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"B1","article-title":"Fast Facts: Health and Economic Costs of Chronic Conditions","year":"2025"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1370\/afm.983","article-title":"Defining comorbidity: implications for understanding health and health services","volume":"7","author":"Valderas","year":"2009","journal-title":"Ann Fam Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.5888\/pcd22.240539","article-title":"Trends in multiple chronic conditions among US adults, by life stage, Behavioral Risk Factor Surveillance System, 2013-2023","volume":"22","author":"Watson","year":"2025","journal-title":"Prev Chronic Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/s12916-022-02487-x","article-title":"Sex-specific patterns and lifetime risk of multimorbidity in the general population: a 23-year prospective cohort study","volume":"20","author":"Velek","year":"2022","journal-title":"BMC Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s12916-022-02427-9","article-title":"Costs of multimorbidity: a systematic review and meta-analyses","volume":"20","author":"Tran","year":"2022","journal-title":"BMC Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph13040391","article-title":"How does sex influence multimorbidity? Secondary analysis of a large nationally representative dataset","volume":"13","author":"Agur","year":"2016","journal-title":"Int J Environ Res Public Health"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(21)00107-9","article-title":"Examining variation in the measurement of multimorbidity in research: a systematic review of 566 studies","volume":"6","author":"Ho","year":"2021","journal-title":"Lancet Public Health"},{"key":"B8","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/s41467-025-67372-6","article-title":"A systematic review and meta-analysis of disease clusters in multimorbidity","volume":"17","author":"Ferris","year":"2025","journal-title":"Nat Commun"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)00757-8","article-title":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"B10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2337\/dsi24-0014","article-title":"The interconnected complexity of diabetes and depression","volume":"38","author":"Beverly","year":"2025","journal-title":"Diabetes Spectr Publ Am Diabetes Assoc"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2023-003903","article-title":"Eight-year nationwide study of the bidirectional association between type 2 diabetes and depression in nearly 8 million German outpatients","volume":"12","author":"Chae","year":"2024","journal-title":"BMJ Open Diabetes Res Care"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2020-001430","article-title":"Diabetes mellitus is associated with a higher risk for major depressive disorder in women than in men","volume":"8","author":"Deischinger","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000001424","article-title":"The menopause transition and women\u2019s health at midlife: a progress report from the Study of Women\u2019s Health Across the Nation (SWAN)","volume":"26","author":"El Khoudary","year":"2019","journal-title":"Menopause"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1017\/S003329171100016X","article-title":"Major depression during and after the menopausal transition: Study of Women\u2019s Health Across the Nation (SWAN)","volume":"41","author":"Bromberger","year":"2011","journal-title":"Psychol Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1177\/15409996251379406","article-title":"Association between depressive symptoms and insulin resistance and the impact of the menopausal transition","volume":"35","author":"Chen","year":"2026","journal-title":"J Womens Health"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgac148","article-title":"Associations of abdominal and cardiovascular adipose tissue depots with HDL metrics in midlife women: the SWAN study","volume":"107","author":"Nasr","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/cells9020276","article-title":"miRNAs as biomarkers in disease: latest findings regarding their role in diagnosis and prognosis","volume":"9","author":"Condrat","year":"2020","journal-title":"Cells"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.addr.2015.05.001","article-title":"An overview of microRNAs","volume":"87","author":"Hammond","year":"2015","journal-title":"Adv Drug Delivery Rev"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S428572","article-title":"Multi-tiered assessment of gene expression provides evidence for mechanisms that underlie risk for type 2 diabetes","volume":"16","author":"Asam","year":"2023","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgac714","article-title":"MicroRNAs associated with incident diabetes in the Diabetes Prevention Program","volume":"108","author":"Flowers","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaf163","article-title":"Body composition differentiates prediabetes phenotype clusters in the Diabetes Prevention Program Study","volume":"110","author":"Stroebel","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1129186","article-title":"The role of microRNAs in depression","volume":"14","author":"Ding","year":"2023","journal-title":"Front Pharmacol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.22.4.623","article-title":"Design and methods for a clinical trial in the prevention of type 2 diabetes","volume":"22","year":"1999","journal-title":"Diabetes Care"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.25.12.2165","article-title":"The Diabetes Prevention Program (DPP)","volume":"25","year":"2002","journal-title":"Diabetes Care"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.23.11.1619","article-title":"The Diabetes Prevention Program: baseline characteristics of the randomized cohort","volume":"23","year":"2000","journal-title":"Diabetes Care"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.1972.11713319","article-title":"Screening depressed patients in family practice: a rapid technic","volume":"52","author":"Beck","year":"1972","journal-title":"Postgrad Med"},{"key":"B27","article-title":"R: A language and environment for statistical computing","year":"2021"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.32614\/cran.package.factoextra","article-title":"Factoextra: Extract and Visualize the Results of Multivariate Data Analyses","author":"Kassambara","year":"2020"},{"key":"B29","unstructured":"cluster: Cluster Analysis Basics and Extensions [R]\n          \n          \n            \n              Maechler\n              M\n            \n            \n              Rousseeuw\n              P\n            \n            \n              Struyf\n              A\n            \n            \n              Hubert\n              M\n            \n            \n              Hornik\n              K\n            \n          \n          \n          2025"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2002-3-7-research0034","article-title":"Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes","volume":"3","author":"Vandesompele","year":"2002","journal-title":"Genome Biol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Ser B Stat Methodol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1177\/17455057251399009","article-title":"Disparities in women\u2019s health and clinical considerations from a translational science perspective: a narrative review and framework for future directions","volume":"21","author":"Warren","year":"2025","journal-title":"Womens Health"},{"key":"B33","article-title":"The weathering hypothesis and the health of African-American women and infants: evidence and speculations","volume":"2","author":"Geronimus","year":"1992","journal-title":"Ethn Dis"},{"key":"B34","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s12110-010-9078-0","article-title":"Do US Black women experience stress-related accelerated biological aging?: a novel theory and first population-based test of Black-White differences in telomere length","volume":"21","author":"Geronimus","year":"2010","journal-title":"Hum Nat"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1186\/s40695-022-00073-y","article-title":"Disparities in reproductive aging and midlife health between Black and White women: the Study of Women\u2019s Health Across the Nation (SWAN)","volume":"8","author":"Harlow","year":"2022","journal-title":"Womens Midlife Health"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1177\/14791641211055837","article-title":"Circulating microRNAs are associated with variability in fasting blood glucose over 12-months and target pathways related to type 2 diabetes: a pilot study","volume":"18","author":"Flowers","year":"2021","journal-title":"Diabetes Vasc Dis Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1419812","article-title":"Longitudinal associations between microRNAs and weight in the Diabetes Prevention Program","volume":"15","author":"Flowers","year":"2024","journal-title":"Front Endocrinol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/5540062","article-title":"miR-320b, a future expected new biomarker for type 2 diabetes mellitus induces dysglycemia by targeting PTEN","volume":"2024","author":"Wang","year":"2024","journal-title":"Int J Endocrinol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.9758\/cpn.2017.15.4.313","article-title":"Peripheral signatures of psychiatric disorders: microRNAs","volume":"15","author":"Camkurt","year":"2017","journal-title":"Clin Psychopharmacol Neurosci Off Sci J Korean Coll Neuropsychopharmacol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/cimb46100644","article-title":"Exploring miRNA biomarkers in major depressive disorder: a molecular medicine perspective","volume":"46","author":"Prodan-B\u0103rbulescu","year":"2024","journal-title":"Curr Issues Mol Biol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25115684","article-title":"MicroRNAs associated with metformin treatment in the Diabetes Prevention Program","volume":"25","author":"Lewis","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.110868","article-title":"MicroRNA biomarkers target genes and pathways associated with type 2 diabetes","volume":"203","author":"Kariuki","year":"2023","journal-title":"Diabetes Res Clin Pract"},{"key":"B43","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jpsychires.2015.07.023","article-title":"Comparison of plasma microRNA levels in drug naive, first episode depressed patients and healthy controls","volume":"69","author":"Camkurt","year":"2015","journal-title":"J Psychiatr Res"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.853633","article-title":"The role of racial and ethnic factors in microRNA expression and risk for type 2 diabetes","volume":"13","author":"Flowers","year":"2022","journal-title":"Front Genet"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.110.226357","article-title":"Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes","volume":"107","author":"Zampetaki","year":"2010","journal-title":"Circ Res"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1007\/s40615-023-01751-x","article-title":"A systematic review of the relationship between discrimination, racism, and type 2 diabetes healthcare outcomes for Black Americans","volume":"11","author":"Anim","year":"2024","journal-title":"J Racial Ethn Health Disparities"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-017-4400-6","article-title":"Perceived racism and incident diabetes in the Black Women\u2019s Health Study","volume":"60","author":"Bacon","year":"2017","journal-title":"Diabetologia"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.2337\/dci22-0044","article-title":"Structural racism as an upstream social determinant of diabetes outcomes: a scoping review","volume":"46","author":"Egede","year":"2023","journal-title":"Diabetes Care"},{"key":"B49","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1111\/1468-0009.12642","article-title":"Conceptualizing the mechanisms of social determinants of health: a heuristic framework to inform future directions for mitigation","volume":"101","author":"Thimm-Kaiser","year":"2023","journal-title":"Milbank Q"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1816057\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T04:33:01Z","timestamp":1782189181000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1816057\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":49,"alternative-id":["10.3389\/fendo.2026.1816057"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1816057","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"article-number":"1816057"}}